| Lyme Disease |
1 |
1 |
| Chronic Disease |
0 |
0.69 |
| Otolaryngology |
0 |
0.48 |
| Pain |
0 |
0.38 |
| Clinical Research |
0 |
0.31 |
| Pain Management |
0 |
0.26 |
| Tick-Borne Diseases |
0 |
0.23 |
| Antibiotics |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.21 |
| Treatment Guidelines |
0 |
0.16 |
| Clinical Guidelines |
0 |
0.15 |
| Fatigue |
0 |
0.15 |
| Orbit |
0 |
0.15 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.15 |
| Preventive Screening |
0 |
0.15 |
| Quality of Life |
0 |
0.13 |
| Vagus Nerve Stimulation |
0 |
0.11 |
| Washington DC |
0 |
0.11 |
| Chronic Fatigue Syndrome |
0 |
0.1 |
| COVID-19 |
0 |
0.1 |
| Genomic Medicine |
0 |
0.1 |
| Allergy |
0 |
0.08 |
| Antigens |
0 |
0.08 |
| Arthritis |
0 |
0.08 |
| Biomarker |
0 |
0.08 |
| Board Certification |
0 |
0.08 |
| Borrelia Burgdorferi |
0 |
0.08 |
| Brain |
0 |
0.08 |
| Centers for Disease Control and Prevention |
0 |
0.08 |
| Central Nervous System |
0 |
0.08 |
| Epigenetics |
0 |
0.08 |
| Epstein-Barr Virus |
0 |
0.08 |
| Face |
0 |
0.08 |
| Fellowship |
0 |
0.08 |
| Genetics |
0 |
0.08 |
| Geographic Tongue |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Intravenous |
0 |
0.08 |
| Nerve |
0 |
0.08 |
| New York |
0 |
0.08 |
| Nightmares |
0 |
0.08 |
| Off-Label Use |
0 |
0.08 |
| Spine |
0 |
0.08 |
| Stress |
0 |
0.08 |
| Tissue |
0 |
0.08 |
| Translational Research |
0 |
0.08 |
| Washington |
0 |
0.08 |